Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 41-50 of 134

Page
per page
  1. ATB-337
    C4592 ATB-337
    Summary: hybrid molecule of an H2S donor and the NSAID diclofenac
      ≤10 mg/mL
  2. IKK-16 (hydrochloride)
    C4569 IKK-16 (hydrochloride)
    Summary: IκB kinases (IKKs) inhibitor
      ≤10 mg/mL
  3. Melanocyte stimulating hormone release inhibiting factor
    A1121 Melanocyte stimulating hormone release inhibiting factor
    Summary: MSH release-inhibiting factor
      ≥59.1 mg/mL
  4. N-Acetylneuraminic acid
    B7905 N-Acetylneuraminic acid
    Summary: Human Endogenous Metabolite
      ≥30.9 mg/mL
  5. Zileuton sodium
    B1207 Zileuton sodium
    Summary: 5-lipoxygenase and leukotrienes inhibitor
      Soluble in DMSO
  6. Mesalamine
    B1969 Mesalamine
    Summary: IKK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.65 mg/mL
  7. HG-9-91-01
    B1052 HG-9-91-01
     2 Citation
    Summary: Pan-SIK (salt-inducible kinases) inhibitor
      ≥56.8 mg/mL
  8. Dimethyl Fumarate
    B1931 Dimethyl Fumarate
    Summary: nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator
  9. Sodium salicylate
    B2028 Sodium salicylate
    Summary: NF-κB inhibitor
  10. Imiquimod hydrochloride
    B1186 Imiquimod hydrochloride
    Summary: Toll-like receptor 7 agonist

Items 41-50 of 134

Page
per page